CH
抗体药类似物
Research Grade Infliximab
All
  • CatalogTD-HF879036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsTA-650,cA2,CAS:170277-31-3
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Infliximab


Catalog No. TD-HF879036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P01375
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names TA-650,cA2,CAS:170277-31-3
Background Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research.
Note For research use only. Not for use in clinical or therapeutic applications.